翻訳と辞書
Words near each other
・ Saxon (disambiguation)
・ Saxon (film)
・ Saxon (firework)
・ Saxon (given name)
・ Saxon (horse)
・ Saxon (surname)
・ Saxon (vehicle)
・ Saxon Academy of Sciences
・ Sax-a-Go-Go
・ Saxa
・ Saxa (food product)
・ Saxa (musician)
・ Saxa Q'awa
・ Saxa Rubra
・ Saxacalli
Saxagliptin
・ Saxapahaw, North Carolina
・ Saxatilomys
・ Saxaul sparrow
・ Saxbe fix
・ Saxby
・ Saxby (surname)
・ Saxby All Saints
・ Saxby Bros Ltd
・ Saxby Chambliss
・ Saxby Pass
・ Saxby railway station
・ Saxby Range
・ Saxby River
・ Saxby, Estonia


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Saxagliptin : ウィキペディア英語版
Saxagliptin

Saxagliptin (rINN), previously identified as BMS-477118, is an oral hypoglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug. In June 2008, it was announced that Onglyza would be the trade name under which saxagliptin will be marketed.
In February 2014, the U.S. FDA announced they were investigating possible cardiac morbidity risk,〔http://www.webmd.com/diabetes/news/20140211/fda-to-investigate-diabetes-drug-saxagliptin-for-possible-heart-failure-risk〕 based on data in an article in the New England Journal.〔 That article concluded "DPP-4 inhibition with saxagliptin did not increase or decrease the rate of ischemic events, though the rate of hospitalization for heart failure was increased. Although saxagliptin improves glycemic control, other approaches are necessary to reduce cardiovascular risk in patients with diabetes."
==Medical uses==
Saxagliptin is used as monotherapy or in combination with other drugs for the treatment of type 2 diabetes. It does not appear to decrease the risk of heart attacks or strokes.〔 It increases the risk of hospitalization for heart failure by about 27%. Like other DPP-4 inhibitors, it has relatively modest HbA1c lowering ability, is associated with a relatively modest risk of hypoglycemia, and does not cause weight gain.
Saxagliptin improved mean HbA1c levels (relative to placebo) in a 24-week trial in people with type 2 diabetes. Combination therapy with saxagliptin and metformin was more effective than saxagliptin or metformin monotherapy.〔 When the relative benefits of increasing the dose of a sulfonylurea or adding saxagliptin were assessed in a study of 768 patients, combination treatments were shown to have a significantly greater impact on fasting blood glucose than increasing the tested glibenclamide dose alone.

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Saxagliptin」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.